Divestiture

MatrixCare goes independent via a Frazier Healthcare acquisition, appointing a new CEO to accelerate innovation in the critical post-acute care tech space.

TPM's sale of ColorLab to its VP marks a strategic split. As TPM chases an AI-driven future, ColorLab gains independence to grow its branding legacy.

A NASDAQ-listed shipping firm scuttles its entire fleet to become a digital asset powerhouse. SVRN's all-in bet on NEAR Protocol is a bold reinvention.

With no revenue and a legacy business sold off, DNA X is betting its future on an AI trading platform. A deep dive into the numbers reveals a high-wire act.

Quimbaya Gold sells a non-core asset in a savvy, non-dilutive deal to fund its flagship Tahami project, signaling a sharp focus on high-potential targets.

An acquisition signals more than growth; it’s a strategic redesign of the clinical trial landscape, challenging giants and empowering innovation.

A beloved New York beach club, profitable yet bankrupt, is for sale. It's a rare chance to own the coast, but what will become of its legacy?

As Trifork's strategic shift to a product-led model yields impressive results, its growing reliance on public sector contracts reveals a new blueprint for stability.

Once a billion-dollar star, Goodfood Market Corp. now seeks a savior in a court-approved sale. A deep dive into the financial collapse and what comes next.

Shedding its IT baggage, Vaso Corp's Q2 results reveal a focused, profitable healthcare strategy. Is this the new blueprint for MedTech success?

The deal signals a major food tech trend: consolidation for all-in-one platforms versus specialization, as iFoodDS doubles down on traceability.

Radian has bet its future on a massive strategic pivot. New CEO Mike Weinbach brings a mortgage tech playbook to a complex global insurance game. Will it work?

Identiv sells its core IoT business, pivoting to a high-risk, high-reward strategy in Physical AI and Compliance SaaS. A deep dive into the deal.

RBC and BMO's $2 billion sale of Moneris isn't just a big payday. It's a strategic retreat from a complex market, fueling a new chapter for Canadian commerce.

National Health Investors' Q2 results reveal a bold strategy: selling a $560M legacy portfolio to fuel an aggressive expansion into private-pay senior housing.

The Ontario pension giant navigates a complex economic landscape with strong public market returns while making a significant strategic pivot towards domestic assets.

The successful sale of Relevate Health is more than a transaction; it's a masterclass in Mountaingate Capital's resilient 'buy-and-build' strategy.

HeartCore Enterprises sells its Vietnamese software venture for a modest sum, signaling a major strategic shift to its high-stakes IPO consulting business.

AIG's strong Q2 results beat profit estimates, powered by underwriting discipline as it completes its strategic pivot away from Corebridge Financial.

Resmed posts record revenue and boosts shareholder returns, but its strategic pivot and operational hurdles reveal a more complex story of medtech leadership.